Presidential Letter on Job Creation Bill Submitted to DPR

    Nur Azizah - 12 Februari 2020 15:29 WIB
    Presidential Letter on Job Creation Bill Submitted to DPR
    Illustration (Photo:Medcom.id/M Rizal)
    Jakarta: Presidential Letter on Job Creation Bill was finally received by the House of Representatives (DPR). It was submitted by Coordinating Minister for Economic Affairs Airlangga Hartarto and Manpower Minister Ida Fauziyah.

    "Pak Airlangga asked me to accompany him to DPR today," Ida said at Presidential Palace Complex on Wednesday, February 12, 2020.

    According to Ida, the letter was given directly to DPR Speaker Puan Maharani. After the handover ceremony, the letter will be discussed during a plenary session.

    The Omnibus Bill on Job Creation consists of 11 clusters. The 11 clusters cover simplification of licensing procedures, investment requirements, manpower, ease in obtaining permits for empowerment and protection of MSMEs, ease of doing business, research support and innovation, government administration, imposition of sanctions, land procurement, investment and government projects, and economic zones.

    It is designed to strengthen the national economy through the improvement of investment ecosystem and competitiveness, particularly in the midst of global uncertainty and economic slowdown. 

    It is expected to be able to gain at least three benefits, namely: to eliminate overlaps between laws and regulations; to improve the efficiency of change process/revocation of laws and regulations; and to remove sectoral egos within law enforcement agencies which shows in various laws and regulation.



    (WAH)

    Bagaimana tanggapan anda mengenai artikel ini?

    Cara untuk mendapatkan Berita terbaru dari kami.

    Ikuti langkah berikut ini untuk mendapatkan notifikasi

    1. Akses Pengaturan/Setting Browser Anda
    2. Akses Notifications pada Pengaturan/Setting Browser Anda
    3. Cari https://m.medcom.id pada List Sites Notifications
    4. Klik Allow pada List Notifications tersebut

    Anda Selesai.

    Powered by Medcom.id